18362-36-2

Basic information

• Product Name: 6-Methylsalicylaldehyde
• Synonyms: 2-Hydroxy-6-methylbenzaldehyde;6-Methylsalicylaldehyde;6-Methyl-2-hydroxybenzaldehyde
• CAS NO: 18362-36-2
• Molecular Formula: C₈H₈O₂
• Molecular Weight: 136.15
• Mol File: 18362-36-2.mol
• Article Data: 31

Chemical Properties

• Melting Point: 32.3°C
• Boiling Point: 230°C (estimate)
• Flash Point: 87.2 °C
• Appearance: /
• Density: 1.1150 (rough estimate)
• Refractive Index: 1.5470 (estimate)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 8.28±0.10(Predicted)
• CAS DataBase Reference: 6-Methylsalicylaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Methylsalicylaldehyde(18362-36-2)
• EPA Substance Registry System: 6-Methylsalicylaldehyde(18362-36-2)

Safety Data

• Hazardous Substances Data: 18362-36-2(Hazardous Substances Data)

Usage

General Description

6-Methylsalicylaldehyde, also known as 6-formyl-2-methylphenol, is a chemical compound with the molecular formula C8H8O2. It is a colorless to pale yellow liquid with a floral, sweet, and balsamic odor. 6-Methylsalicylaldehyde is commonly used as a flavoring agent in the food industry and as a fragrance ingredient in perfumes and cosmetic products. It is also used in the synthesis of pharmaceuticals and as a starting material for the preparation of various organic compounds. Additionally, 6-Methylsalicylaldehyde exhibits antimicrobial and antioxidant properties. However, it is important to handle this compound with caution as it may cause skin and eye irritation, and it is flammable.

Upstream product

• 67-66-3 chloroform 
• 108-39-4 3-methyl-phenol 
• 75-25-2 Bromoform 
• 54884-55-8 2-methoxy-6-methyl-benzaldehyde 
• 50-00-0 formaldehyd 
• 7647-01-0 hydrogenchloride 
• 7446-70-0 aluminium trichloride 
• 71-43-2 benzene 
• 53300-10-0 2-amino-4-methyl-cycloheptatrienone 
• 2944-49-2 2,3-dimethylanisole 
• 4885-02-3 Dichloromethyl methyl ether 
• 529-20-4 2-methylphenyl aldehyde 
• 940003-50-9 3-methyl-2-(trimethylsilyl)phenyl trifluoromethanesulfonate 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 148228-52-8 C₂₆H₃₄N₄O₄ 
• 1360618-17-2 4-[(2-formyl-3-methylphenoxy)methyl]benzoic acid methyl ester 
• 1360618-29-6 4-((2-formyl-3-methylphenoxy)methyl)benzoic acid 
• 1360618-27-4 C₂₅H₃₅NO₆Si 
• 54884-55-8 2-methoxy-6-methyl-benzaldehyde 
• 72473-09-7 coahuilensol, methyl ether 
• 5670-24-6 4-methylbenzofuran-2-carboxylic acid 
• 567-61-3 2-hydroxy-6-methylbenzoic acid 
• 51985-20-7 3,6-dihydroxy-2-methyl-benzaldehyde 
• 526-75-0 2,3-Dimethylphenol 
• 29922-52-9 2-hydroxymethyl-3-methylphenol 
• 115560-68-4 2-Methoxymethoxy-6-methyl-benzaldehyde 

Relevant articles and documents

Phytochemical study on American plants I. Two new phenol glucosides, together with known biflavones and diterpene, from leaves of Juniperus occidentalis Hook.

Two new phenol glucosides termed juniperosides I (1) and II (2) were isolated, together with known two biflavones, cupressuflavone and amentoflavone and a diterpene, 3beta-hydroxy sandaracopimaric acid, from leaves of Juniperus occidentalis HOOK. (Cupress

Polymerizable Materials Based On Dimerizable Benzaldehyde Derivatives

The present invention relates to polymerizable and photochemically crosslinkable compositions which contain at least one polymerizable benzaldehyde derivative according to general formula I and which are suitable as materials for technical and medical app

Protection-Group-Free Synthesis of Sequence-Defined Macromolecules via Precision λ-Orthogonal Photochemistry

An advanced light-induced avenue to monodisperse sequence-defined linear macromolecules via a unique photochemical protocol is presented that does not require any protection-group chemistry. Starting from a symmetrical core unit, precision macromolecules

DUAL AGONISTS OF FXR AND PPARδ AND THEIR USES

The present invention relates to small molecule compounds and their use as agonists of farnesoid X receptor (FXR) and/or peroxisome proliferator activated receptor delta (PPARδ). The present invention also relates to the use of said compounds in the treatment of metabolic diseases and respective methods of treatment.